Skip to main content

Articles

Page 83 of 108

  1. Authors: S Rodenhuis, M Bontenbal, LVAM Beex, WM Smit, MA Nooij, EE Voest, E van der Wall, P Hupperets, Harm van Tinteren, HL Peterse, MJ van de Vijver and EGE de Vries
    Citation: Breast Cancer Research 2005 7(Suppl 1):S23

    This article is part of a Supplement: Volume 7 Supplement 1

  2. Authors: J Giannios, P Lambrinos, E Maragudakis and N Alexandropoulos
    Citation: Breast Cancer Research 2005 7(Suppl 1):P13

    This article is part of a Supplement: Volume 7 Supplement 1

  3. Although breast carcinoma (BC) is the most common malignancy affecting Jordanian females and the affected population in Jordan is younger than that in the West, no information is available on its biological ch...

    Authors: Nidal M Almasri and Mohammad Al Hamad
    Citation: Breast Cancer Research 2005 7:R598
  4. We have shown previously that overexpression of constitutively active Akt or activation of Akt caused by constitutively active Ras or human epidermal growth factor receptor-2 (HER2) confers on breast cancer ce...

    Authors: Xinqun Li, Yang Lu, Ke Liang, Bolin Liu and Zhen Fan
    Citation: Breast Cancer Research 2005 7:R589
  5. Certain laminins of vascular basement membranes have been identified in human breast tumors and brain gliomas that share the same β1 chain. These laminins are new carcinoma angiogenic markers and might represe...

    Authors: Eggehard Holler
    Citation: Breast Cancer Research 2005 7:166
  6. Once metastasis has occurred, the possibility of completely curing breast cancer is unlikely, particularly for the 30 to 40% of cancers overexpressing the gene for HER2/neu. A vaccine targeting p185, the protein ...

    Authors: Xiaoyan Wang, Jian-Ping Wang, Xiao-Mei Rao, Janet E Price, Heshan S Zhou and Lawrence B Lachman
    Citation: Breast Cancer Research 2005 7:R580
  7. Menopausal hormone therapy (HT) is typically withheld from breast cancer survivors because of concerns about risk for recurrence. Our objectives were to estimate the effects of HT on recurrence in breast cance...

    Authors: Nananda F Col, Jung A Kim and Rowan T Chlebowski
    Citation: Breast Cancer Research 2005 7:R535
  8. Alcohol consumption is a well-established risk factor for breast cancer. Some studies have suggested that the risk of breast cancer associated with alcohol consumption is greater for women with a history of be...

    Authors: Rulla M Tamimi, Celia Byrne, Heather J Baer, Bernie Rosner, Stuart J Schnitt, James L Connolly and Graham A Colditz
    Citation: Breast Cancer Research 2005 7:R555
  9. Women younger than 35 years who are diagnosed with breast cancer tend to have more advanced stage tumors and poorer prognoses than do older women. Pregnancy is associated with elevated exposure to estrogen, wh...

    Authors: Joan A Largent, Argyrios Ziogas and Hoda Anton-Culver
    Citation: Breast Cancer Research 2005 7:R541
  10. Metastasis involves the emigration of tumor cells through the vascular endothelium, a process also known as diapedesis. The molecular mechanisms regulating tumor cell diapedesis are poorly understood, but may ...

    Authors: Mary-Ann Pollmann, Qing Shao, Dale W Laird and Martin Sandig
    Citation: Breast Cancer Research 2005 7:R522
  11. Because CYP17 can influence the degree of exposure of breast tissues to oestrogen, the interaction between polymorphisms in this gene and hormonal risk factors is of particular interest. We attempted to replicate...

    Authors: Jiun-Horng Chang, Dorota M Gertig, Xiaoqing Chen, Gillian S Dite, Mark A Jenkins, Roger L Milne, Melissa C Southey, Margaret RE McCredie, Graham G Giles, Georgia Chenevix-Trench, John L Hopper and Amanda B Spurdle
    Citation: Breast Cancer Research 2005 7:R513
  12. A technique called in vivo magnetic resonance spectroscopy (MRS) can be performed along with magnetic resonance imaging (MRI) to obtain information about the chemical content of breast lesions. This information c...

    Authors: Patrick J Bolan, Michael T Nelson, Douglas Yee and Michael Garwood
    Citation: Breast Cancer Research 2005 7:149
  13. Matrix metalloproteinase 12 (MMP12) is a proteolytic enzyme responsible for cleavage of plasminogen to angiotensin, which has an angiostatic effect. Using data from a population-based case–control study conduc...

    Authors: Aesun Shin, Qiuyin Cai, Xiao-Ou Shu, Yu-Tang Gao and Wei Zheng
    Citation: Breast Cancer Research 2005 7:R506
  14. The TP53-binding protein (53BP1) has been shown to influence TP53-mediated transcriptional activation, thus playing a pivotal role in DNA damage signalling. Genetic aberrations in TP53 and in ATM and CHEK2 predis...

    Authors: Bernd Frank, Kari Hemminki, Justo Lorenzo Bermejo, Rüdiger Klaes, Peter Bugert, Barbara Wappenschmidt, Rita K Schmutzler and Barbara Burwinkel
    Citation: Breast Cancer Research 2005 7:R502
  15. Mutations in BRCA1, BRCA2, ATM, TP53, CHK2 and PTEN account for only 20–30% of the familial aggregation of breast cancer, which suggests the involvement of additional susceptibility genes. The ATR (ataxia-telangi...

    Authors: Katri Heikkinen, Virpi Mansikka, Sanna-Maria Karppinen, Katrin Rapakko and Robert Winqvist
    Citation: Breast Cancer Research 2005 7:R495
  16. Recent publications have classified breast cancers on the basis of expression of cytokeratin-5 and -17 at the RNA and protein levels, and demonstrated the importance of these markers in defining sporadic tumou...

    Authors: Barry A Gusterson, Douglas T Ross, Victoria J Heath and Torsten Stein
    Citation: Breast Cancer Research 2005 7:143
  17. Our goal was to specifically render tumor cells susceptible to natural cytolytic anti-αGal antibodies by using a murine α1,3galactosyltransferase (mαGalT) transgene driven by a designed form of HER2/neu promoter ...

    Authors: Marion Lanteri, Laurence Ollier, Valérie Giordanengo and Jean-Claude Lefebvre
    Citation: Breast Cancer Research 2005 7:R487
  18. It has been well documented that the pineal hormone, melatonin, which plays a major role in the control of reproduction in mammals, also plays a role in the incidence and growth of breast and mammary cancer. T...

    Authors: Véronique Lenoir, Marianne Beau Yon de Jonage-Canonico, Marie-Hélène Perrin, Antoine Martin, Robert Scholler and Bernard Kerdelhué
    Citation: Breast Cancer Research 2005 7:R470

Annual Journal Metrics

  • 2022 Citation Impact
    7.4 - 2-year Impact Factor
    7.4 - 5-year Impact Factor
    1.764 - SNIP (Source Normalized Impact per Paper)
    2.408 - SJR (SCImago Journal Rank)

    2023 Speed
    20 days submission to first editorial decision for all manuscripts (Median)
    129 days submission to accept (Median)

    2023 Usage 
    2,432,781 downloads
    1,561 Altmetric mentions